For patients battling neurodegenerative diseases like ALS, Parkinson's, Alzheimer's and other dementias, delivering disease-fighting antibody drugs directly to the brain has proven to be a difficult task. ...

Researchers have mapped out a dual-action therapeutic strategy to cross the blood-brain barrier and eliminate pathological proteins